Komori
Toray Industries (3402) · RiskMaterialised

Litigation Risks Relating to Intellectual Property, Product Liability, Environmental Matters, Labor Issues and Other Areas

First written in FY2017. 2 of 4 entries say "Materialised", first in FY2025. Latest entry: FY2026.

4entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2017 – FY2019MaterialisedFY2025 – FY20262017: 120172018: 020182019: 120192020: 020202021: 020212022: 020222023: 020232024: 020242025: 120252026: 12026
Same theme, other companies

Toray Industries moved to the "Worse" side of this theme in 2025, 1 year after the typical company in this theme (2024).

The whole theme swung hardest in 2024: 4 of 10 companies on the "Worse" side.

2 other companies' latest entry also says "Materialised".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 46 companies compared. The sentences above are computed from all 46.
Full recordFilings, disclosures and news, newest first
  1. FY2026MaterialisedAnnual report

    「The damages awarded under this judgment include an amount equivalent to damages relating to the joint business between Torii Pharmaceutical Co., Ltd. and our company. We have agreed that, after the judgment becomes final, the damages and late-payment interest will be divided equally between Torii Pharmaceutical Co., Ltd. and our company with respect to the damages relating to the joint business.」

    Regarding the use-patent litigation over Remitch OD Tablets, the company states that damages and late-payment interest were received, while the final allocation remains undetermined pending the appeal.
  2. FY2025MaterialisedAnnual report

    「The judgment found that Sawai Pharmaceutical and Fuso Pharmaceutical Industries’ manufacture and sale of Sawai products and Fuso products during the term of the patent at issue constituted infringement of that patent, upheld our claim for damages, and ordered Sawai Pharmaceutical to pay ¥14,290,939,291 and Fuso Pharmaceutical Industries to pay ¥7,472,878,838 in damages and late-payment interest.」

    Regarding intellectual property and litigation risk, a judgment handed down by the Intellectual Property High Court on 27 May 2025 found infringement of the use patent for Remitch OD Tablets. The opposing parties have filed appeals and other actions, and the final outcome remains undetermined.
  3. FY2019RestatedAnnual report

    「As the Group conducts a broad range of business activities, it faces the risk of becoming subject to various lawsuits involving intellectual property rights, product liability, environmental matters and labor matters, among others. If a serious lawsuit is filed, the Group’s operating results and financial condition may be adversely affected.」

    The Group continues to disclose litigation risks involving intellectual property, product liability, environmental matters and labor matters, among others.
  4. FY2017First statedAnnual report

    「As the Group conducts a broad range of business activities, it faces the risk of becoming subject to various lawsuits involving intellectual property rights, product liability, environmental matters and labor matters, among others. If a serious lawsuit is filed, the Group’s operating results and financial condition may be adversely affected.」

    Litigation risk was disclosed as an independent major risk for the first time, covering intellectual property, product liability, environmental matters and labor matters.
Moved together

"Risk of declining domestic and overseas demand, falling product market prices and intensifying competition" moved the same way as this thread, in the same document, in 2 of its 4 moves.

22★12
  1. ★This thread
  2. 1Risk of declining domestic and overseas demand, falling product market prices and intensifying competition2×
  3. 2Risk of fluctuations in exchange rates, interest rates, and the value of securities and pension assets2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Toray Industries's next results are scheduled for 2026-11-10. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.